Does hepatitis C viremia or genotype predict the risk of mortality in individuals co-infected with HIV?
about
Treatment optimization for HIV/HCV co-infected patients.HIV and hepatitis C co-infection in Europe, Israel and Argentina: a EuroSIDA perspective.Effect of abacavir on sustained virologic response to HCV treatment in HIV/HCV co-infected patients, Cohere in Eurocoord.Prevalence and Risk Factors of HCV/HIV Co-Infection and HCV Genotype Distribution in North-Eastern PolandEpidemiological implications of HIV-hepatitis C co-infection in South and Southeast AsiaDemographical, Viro-Immunological, Clinical and Therapeutical Characteristics of HIV-Infected Patients in an "Epidemiologically Unexplored" Region of Italy (Calabria Region): the CalabrHIV Cohort.Impact of universal access to hepatitis C therapy on HIV-infected patients: implementation of the Spanish national hepatitis C strategy.Treatment of genotype 2 and genotype 3 hepatitis C virus (HCV) infection in human immunodeficiency virus positive patients.Hepatitis C virus infection in patients with HIV-1: epidemiology, natural history and management.Optimal therapy of HIV/HCV co-infected patients with direct acting antivirals.Hepatitis C and HIV Coinfection for Social Workers in Public Health, Medical and Substance Use Treatment Settings.HIV and viral hepatitis co-infection in New York City, 2000-2010: prevalence and case characteristics.High rate of hepatitis C virus (HCV) recurrence in HIV-infected individuals with spontaneous HCV RNA clearance.Changes in liver fibrosis in HIV/HCV-coinfected patients following different outcomes with peginterferon plus ribavirin therapy.Consequence of HIV and HCV co-infection on host immune response, persistence and current treatment options.Hepatitis C coinfection adversely affects the life expectancy of people living with HIV in northwestern Poland.
P2860
Q30235034-8EBED568-EFB8-4E42-A47E-928A2635CA86Q34260569-2A736322-0A23-4BFC-8627-721AC033A787Q35832820-B2656FD8-3D6A-44C6-9104-71F77D698151Q35964789-9021EC23-2F5A-4FBC-803B-DA818CEAD213Q35980818-932A5F97-7912-4FE4-976C-18273D974DADQ36208301-AF9492CA-B6D8-40F3-8E66-BD04B49C9238Q37642114-1344065F-FA3F-49F1-96CF-198D8D80066EQ38164262-6A7A9563-9F5D-430F-A95B-C6D30492BEA2Q38180719-23E65412-0C85-48D9-9A44-5C50FFD98B0DQ38295822-06115658-6328-4D5D-9483-4784C669C92CQ38391718-9F0AD60A-7875-49ED-BBE8-9296F6B78346Q42196370-AD7C9719-BB79-482A-BC61-D27921F32CCEQ42215928-79A7C333-09CF-473C-AAB8-334CF588BCFBQ42218530-0AB85E2C-784F-4E49-8827-9850E3A04317Q54243856-1364C5C3-7503-4F91-939E-105D11A4E946Q55411140-648D1886-C479-4F11-872B-613AD51235E5
P2860
Does hepatitis C viremia or genotype predict the risk of mortality in individuals co-infected with HIV?
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Does hepatitis C viremia or ge ...... ividuals co-infected with HIV?
@en
Does hepatitis C viremia or ge ...... ividuals co-infected with HIV?
@nl
type
label
Does hepatitis C viremia or ge ...... ividuals co-infected with HIV?
@en
Does hepatitis C viremia or ge ...... ividuals co-infected with HIV?
@nl
prefLabel
Does hepatitis C viremia or ge ...... ividuals co-infected with HIV?
@en
Does hepatitis C viremia or ge ...... ividuals co-infected with HIV?
@nl
P2093
P50
P1476
Does hepatitis C viremia or ge ...... ividuals co-infected with HIV?
@en
P2093
Bernd Kupfer
EuroSIDA in EuroCoord
Lars Peters
Marcelo H Losso
Peter Reiss
P304
P356
10.1016/J.JHEP.2013.04.005
P50
P577
2013-04-11T00:00:00Z